COVID - 19 Vaccination Update - Day 484 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 40 Second

Posted On: 14 MAY 2022 9:22 PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 191.30 Crore (1,91,30,82,445) today. More than13 lakh (13,47,702) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10406129
	2^nd Dose	10029412
	Precaution Dose	5022560
FLWs	1^st Dose	18417586
	2^nd Dose	17564834
	Precaution Dose	8166705
Age Group 12-14 years	1^st Dose	31717132
	2^nd Dose	12064007
Age Group 15-18 years	1^st Dose	58961755
	2^nd Dose	43969464
Age Group 18-44 years	1^st Dose	556577917
	2^nd Dose	484607265
	Precaution Dose	405373
Age Group 45-59 years	1^st Dose	203138492
	2^nd Dose	189599368
	Precaution Dose	990504
Over 60 years	1^st Dose	127011920
	2^nd Dose	118177919
	Precaution Dose	16254103
Cumulative 1^st dose administered		1006230931
Cumulative 2^nd dose administered		876012269
Precaution Dose		30839245
Total		1913082445

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 14^th April, 2022 (484^thDay)
HCWs	1^st Dose	36
	2^nd Dose	520
	Precaution Dose	14035
FLWs	1^st Dose	60
	2^nd Dose	898
	Precaution Dose	30389
Age Group 12-14 years	1^st Dose	171873
	2^nd Dose	288395
Age Group 15-18 years	1^st Dose	31323
	2^nd Dose	117763
Age Group 18-44 years	1^st Dose	34626
	2^nd Dose	322918
	Precaution Dose	36686
Age Group 45-59 years	1^st Dose	7357
	2^nd Dose	76649
	Precaution Dose	45187
Over 60 years	1^st Dose	4633
	2^nd Dose	51756
	Precaution Dose	112598
Cumulative 1^st dose administered		249908
Cumulative 2^nd dose administered		858899
Precaution Dose		238895
Total		1347702

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.